1 |
Bush, K. and S. B. Singer. 1989. Biochemical characteristics of extended broad spectrum -lactamases. Infection 17: 429-433
DOI
|
2 |
Casellas, J. M. and M. Goldberg. 1989. Incidence of strains producing extended-spectrum -lactamase in Argentina. Infection 17: 434-436
DOI
|
3 |
Jacoby, G. A. 1997. Extended spectrum -lactamases and other enzymes providing resistance to oxyimino- -lactams. Infect. Dis. Clin. NA. 11: 875-887
DOI
ScienceOn
|
4 |
Jarlier, V., M. H. Nicolas, G. Fournier, and A. Phillippon. 1988. Extended-spectrum -lactamases conferring transferable resistance to newer -lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10: 867-878
|
5 |
Lee, J. H., I. K. Bae, S. B. Kwon, and S. H. Jeong. 2004. Prevalence of CTX-M-type Extended-Spectnun -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates in Korea, 2003. Korean J. Clin. Microbiol. 7: 111-118
|
6 |
Lee, S. H., J. Y. Kim, S. H. Shin, Y. J. An, Y. W. Choi, and Y. C. Jung. 2003. Dissemination of SHV-12 and characterization of New AmpC-type -lactamase genes among clinical isolates of Enterobacter species in Korea. J. Clin. Microbiol. 41: 2477-2482
DOI
|
7 |
Medeiros, A. A. 1984. -Lactamases. Br. Med. Bull. 40: 18-27
|
8 |
Moland, E. S., J. A. Black, A. Hossain, N. D. Hanson, K. S. Thomson, and S. Pottumarthy. 2003. Discovery of CTX-M-like extended-spectrum-lactamases in Escherichia coli isolates from five U.S. states. Antimicrob. Agents Chemother. 47: 2382-2383
DOI
|
9 |
Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken. 1999. Klebsiella, Enterobacter, Citrobacter; and Serratia in Manual of Clinical Microbiology, pp. 475-482. 7th Ed. Washington: American Society for Microbiology
|
10 |
National Committee for Clinical Laboratory Standards. 2000. Performance standards for antimicrobial disk susceptibility testing, Tenth informational supplement, M100-S10(M2). Wayne, Pa: National Committee for Clinical Laboratory Standards
|
11 |
Poyart, C., P. Mugnier, G. Quesne, P. Berche, and P. Trieu-Cuot. 1998. A novel extended-spectrum TEM-type -lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 42: 108-113
|
12 |
Coudron, P. E., E. S. Moland, and C. C. Sanders. 1997. Occurrence and detection of extended-spectrum -lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J. Clin. Microbiol. 35: 2593-2597
|
13 |
Winokur, P. L., R. Canton, J. M. Casellas, and N. Legakis. 2001. Variations in the prevalence of strains expressing an extended-spectrum-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacificregion. Clin. Infect. Dis. 32: 94-103
|
14 |
Bonnet, R. 2004. Growing group of extended-spectrum-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48: 1-14
DOI
|
15 |
Bradford, P. A., Y. Yang, D. Sahm, I. Grope, D. Gardovska, and G. Storch. 1998. CTX-M-5, a novel cefotaxime-hydrolyzing -lactamases from an outbreak of Salmonella typhimurium in Latvia. Antimicrob. Agents Chemother. 42: 1980-1994
|
16 |
Kim, B. L., S. H. Jeong, J. Y. Koo, K. W. Lee, Y. S. Chong, T. J. Jeon, H. Y. Hwang, and M. H. Kim. 1999. Prevalence of Extended spectrum -lactamase producing Enterobacteriaceae and evaluation of methods for detection. Kor. J. Clin. Microbiol. 2: 28-39
|
17 |
Pai, H., E. H. Choi, H. J. Lee, J. Y. Hong, and G. A. Jacoby. 2001. Identification of CTX-M-14 extended-spectrum -lactamase in clinical isolates of Shigella sonnei, Escherichia coli, Klebsiella pneumoniae in Korea, J. Clin. Microbiol. 39: 3747-3749
DOI
ScienceOn
|
18 |
Livermore, D. M. 1995. -lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8: 557-584
|
19 |
Ma, L., Y. Ishii, M. Ishiguro, and H. Matsuzawa. 1998. Cloning and sequencing of the gene encoding Toho-2, a class A -lactamase preferentially inhibited by tazobactam. Antimicrob. Agents Chemother. 42: 1181-1186
|
20 |
National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-5th edition: approved standards. M7-A5. Wayne, Pa: National Committee for Clinical Laboratory Standards
|
21 |
Wang, H., S. Kelkar, W. Wu, and M. Chen. 2003. Clinical isolates of Enterobacteriaceae producing extended-spectrum -lactamases: prevalence of CTX-M-3 at a hospital in China. Antimicrob. Agents Chemother. 47: 790-793
DOI
|
22 |
Gniadkowski, M., I. Schneider, A. Palucha, R. Jungwirth, B. Mikiewicz, and A. Bauernfeind. 1998. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob. Agents Chemother. 42: 827-832
|
23 |
Song, W. G., K. W. Lee, S. J. Kim, S. H. Jeong, C. H. Chang, and H. J. Shin. 2000. Extended-spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae isolates from 12 hospital in Korea. Kor. J. Chemother. 18: 401-410
|
24 |
Hong, S. G., J. Lee, D. Yong, E. C. Kim, S. H. Jeong, and Y. J. Park. 2004. Antimicrobial resistance of clinically important bacteria isolated from 12 hospitals in Korea. Kor. J. Clin. Microbiol. 7: 171-177
|
25 |
Tzouvelekis, L. S., E. Tzelepi, P. T. Tassios, and N. J. Legakis. 2000. CTX-M-type -lactamases: an emerging group of extended- spectrum enzymes. Int. J. Antimicrob. Agents. 14: 137-143
DOI
ScienceOn
|
26 |
Mammeri, H., G. Laurans, M. Eveillard, S. Castelain, and F. Eb. 2001. Coexistence of SHV-4 and TEM-24 producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital. J. Clin. Microbiol. 39: 2184-2190
DOI
ScienceOn
|
27 |
Dumarche, P., C. De Champs, D. Sirot, C. Chanal, R. Bonnet, and J. Sirot. 2002. TEM derivative-producing Enterobacter aerogenes strains: dissemination of a prevalent clone. Antimicrob. Agents Chemother. 46: 1128-1131
DOI
|
28 |
Jacoby, G. A. and A. A. Medeiros. 1991. More extended-spectrum- lactamases. Antimicrob. Agents Chemother. 35: 1697-1704
|
29 |
Kim, Y. T., T. U. Kim, and H. S. Baik. 2006. Characterization of Extended Spectrum -Lactamase Genotype TEM, SHV and CTX-MKlebsiella pneumoniae Isolated from Clinical Specimens in Korea. J. Microbiol. Biotechnol. 16: 889-895
과학기술학회마을
|
30 |
Stobberingh, E. E., J. Arends, J. A. Hoogkamp-Korstanje, W. H. Goessens, M. R. Visser, and A. G. Buiting. 1999. Occurrence of extended-spectrum -lactamases (ESBL) in Dutch hospitals. Infection 27: 348-354
DOI
|
31 |
David, L., L. Paterson, M. Kristine, M. Hujer, Y. Bethany, D. Michael, and D. Bonomo. 2003. Extended-Spectrum-Lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV-and CTX-M-Type- -lactamases. Antimicro. Agents Chemother. 34: 3554-3560
|
32 |
Canton, R., A. Oliver, T. M. Coque, C. Varela Mdel, J. C. Perez- Diaz, and F. Baquero. 2002. Epidemiology of extended-spectrum -lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period. J. Clin. Microbiol. 40: 1237-1243
DOI
|
33 |
Bauernfeind, A., I. Stemplinger, R. Jungwrirth, S. Ernst, and J. M. Casellas. 1996. Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases. Antimicrob. Agents Chemother. 40: 509-513
|
34 |
Bradford, P. A. 2001. Extended-spectrum -lactamases in the 21th century: characterization, epidermiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14: 933-951
DOI
ScienceOn
|
35 |
Nordmann, P. 1998. Trends in -lactam resistance among Enterobacteriaceae. Clin. Infect. Dis. 27: 100-106
DOI
ScienceOn
|
36 |
Ouellette, M., G. C. Paul, A. M. Philippon, and P. H. Roy. 1988. Oligonucleotide probes (TEM-1, OXA-1) versus isoelectric focusing in -lactamase characterization of 114 resistant strains. Antimicrob. Agents Chemother. 32: 397-399
|
37 |
Sabate, M., R. Tarrago, F. Navarro, E. Miro, C. Verges, and J. Barbe. 2000. Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing -lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrob. Agents Chemother. 44: 1970-1973
DOI
|
38 |
Yagi, T., H. Kruokawa, N. Shibata, K. Shibayama, and Y. Arakawa. 2000. A preliminary survey of extended-spectrum -lactamase (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol. Lett. 184: 53-56
|
39 |
Nuesch-Inderbinen, M. T., F. H. Kayser, and H. Hachler. 1997. Survey and molecular genetics of SHV -lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob. Agents Chemother. 41: 943-949
|
40 |
Sirot, D. 1995. Extended-spectrum plasmid-mediated -lactamases. J. Antimicrob. Chemother. 36: 19-34
DOI
ScienceOn
|
41 |
Forbes, B. A., D. F. Sahm, and A. S. Weissfeld. 2002. Enterobacteriaceae in Baily & scott's Diagnostic Microbiology. 11th Ed. Mosby Co. 365-375
|
42 |
Jacoby, G. A. and L. S. Munoz-Price. 2005. The new -lactamases. New Engl. Med. 352: 380-391
DOI
ScienceOn
|